IR-Akt activation has an anti-atherosclerotic effect, which indicate that S597 can prevent advanced atherosclerosis in a mouse model of MetS, such as hardening of the arteries (Kanter et al., 2018). This evidence concerns the gene AKT1 and metabolic syndrome.